Skip to content

Clinical trials

Completed Bronchial Diseases trials in Canada

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchial Diseases Status: Completed Country / region: Canada Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20092
20111
20131
20143
20152
20162
20171
20181
20191
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed15

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
AstraZeneca10
Altair Therapeutics, Inc.1
National Heart, Lung, and Blood Institute (NHLBI)1
Novartis Pharmaceuticals1
Pulmatrix Inc.1
Upstream Bio Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchial Diseases15
Lung Diseases14
Respiratory Tract Diseases14
Asthma13
Lung Diseases, Obstructive11
Hypersensitivity3
Hypersensitivity, Immediate3
Immune System Diseases3
Respiratory Hypersensitivity3
Bronchiectasis1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.